XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

172 hedge funds and large institutions have $1.9B invested in Acceleron Pharma Inc. in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 8 closing their positions.

Holders
172
Holders Change
+6
Holders Change %
+3.61%
% of All Funds
3.78%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
14
Increased
58
Reduced
62
Closed
8
Calls
$5.12M
Puts
$7.66M
Net Calls
-$2.54M
Net Calls Change
-$2.2M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$31M
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$29.1M
3
BlackRock
3
BlackRock
New York
$204M
4
CS
4
Candriam SCA
Luxembourg
$21.8M
5
SI
5
Sofinnova Investments
California
$16.1M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.99M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$235M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$135M
4
State Street
4
State Street
Massachusetts
$56.2M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$2.26M
Name Holding Trade Value Shares
Change 		Shares
Change %
FRM
176
Fox Run Management
Connecticut
– -$234K -5,685 Closed
HF
177
HRT Financial
New York
– -$215K -5,248 Closed
WCA
178
Windsor Creek Advisors
Vermont
– -$205K -5,000 Closed
IWC
179
Integrated Wealth Concepts
Massachusetts
– -$205K -5,000 Closed
Simplex Trading
180
Simplex Trading
Illinois
– -$198K -4,826 Closed
4 5 6 7
8